Alexander Ditchfield
Managing Director, Head of New York
纽约
Alexander Ditchfield is a Managing Director and Head of BDA’s New York office. Clients for whom he has advised on transactions include Aterian Investment Partners, CHS, CITIC Capital, Kerry, Littlejohn, On Semi, MacLean-Fogg, Molex, and Pfizer, among others.
Prior to moving to New York in 2016, he worked in BDA’s Shanghai and Hong Kong offices for seven years. He speaks Mandarin and English.
Recent transactions
acquired majority stake in
2024
医疗
received investment from
2023
制造业
a portfolio company of
has been sold to
2023
制造业
divested Niigata fab to
Sangyo Sosei and Fukuoka Capital
2022
制造业
acquired by
a portfolio company of
2022
化学制品
has been acquired by
2022
科技
divested ASG Print to
and
2021
制造业
has been acquired by
2021
化学制品
divested China phenolic resins plant to
2021
化学制品
divested to
a portfolio company of
2020
化学制品
Presswerk Krefeld a portfolio company of
has been acquired by
2017
制造业
raised equity capital and new Asian partnerships
2016
化学制品
CHS Ningbo Protein Foods a subsidiary of CHS has been acquired by
Shandong Wonderful
2016
消费品
a portfolio company of
has been acquired by
2016
制造业
divested
to
2014
制造业
divested
to American Tire Distributors
2014
制造业
divested KDM to Superior Capital Partners / Nelson-Miller
2012
制造业